Egypt Hepatitis C Market Analysis


  • Type: Common Disease Area
  • Published : June 2021
  • Region: Africa
  • Country: Egypt
  • Report ID : 4783

  • Format: PPT, PDF

Egypt Hepatitis C Drug Market: Segmentation by Drug Type (Entecavir, Tenofovir, Lamivudine, Adefovir, Telbivudine, and Others), Route of Administration (Oral, Parenteral, others), End Users (Hospital & Clinics Diagnostic Centres and Others), and Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) – Growth, Trends, And Forecasts (2019 – 2028)

 Published Date: June, 2021




SKU: 4783 Categories: ,

Egypt’s Hepatitis C drug market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Hepatitis C is a viral infection that causes severe damage such as inflammation of the liver and can spread through contaminated blood. The advanced stages of hepatitis C can also lead to liver damage, thereby creating severe health risks. The severity of hepatitis C has created a huge emphasis on the research and development of drugs associated with the treatment of this disease.

Egypt continues to report one of the highest incidences of Hepatitis C (HCV) in the world, estimated at 10-15mn sufferers in 2017. Secondary problems associated with HCV include cirrhosis of the liver, which was responsible for around half a million DALYs lost in Egypt in 2017. The Egyptian government is upholding its pledge towards reducing the HCV burden in the country. The MoH recently announced its plans to strengthen the national campaign against the virus, largely through greater cooperation with pharmaceutical manufacturers of antivirals.

Market Drivers

The escalating demand for hepatitis C drugs has yielded several regulatory approvals for associated drugs. Increasing regulatory approvals for related drugs and recombinant products will constitute an increase in the Hepatitis C Drugs Market value in the coming years.

Egypt, one of the countries with the largest burden of hepatitis C infection in the world, has made significant advances since 2018 towards hepatitis C elimination through a large countrywide public health effort to screen the entire population aged 18 years and older (a target population of 62.5 million) and link those in need to care. Nearly 50 million adults and 9 million children aged 12–18 years were screened, and 1.5 million additional persons had started treatment by mid-2019. This constitutes one of the largest public health efforts to date towards hepatitis C elimination in low- and middle-income countries. Egypt now plans to support other countries in the sub-Saharan African region in their scale-up efforts.

According to World Bank’s projections, if Egypt continues its current treatment path, it will spend nearly $4 billion on Hepatitis C by 2030. This will improve and boost the Hepatitis C drug demand in the Egyptian market.

However, Egypt and Pakistan reduced their order volumes by 60 percent in 2019. These countries have treated the majority of their diagnosed patients and are now focusing on case-finding activities. As countries approach elimination by treating most of their patients, the demand for DAAs in those specific countries might peak and then decline.

1. Hepatitis C Drug Market Overview…………………………………………………..
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rising Disease Burden of Hepatitis C
B. Demand for Better Treatment
C. Awareness Amongst People, Govt. Initiatives
3. Major Types of Hepatitis C
I. Acute Hepatitis C
II. Chronic Hepatitis C
III. Others
4. Hepatitis C Drug Market Segmentation……………………………………………
A. Drug Type
I. Entecavir
II. Tenofovir
III. Lamivudine
IV. Adefovir
V. Telbivudine
VI. others
B. Route of Administration
I. Oral
II. Parenteral
III. Others
C. End-User
I. Hospital & Clinics
II. Diagnostic Centres
III. Others
D. Distribution Channel
I. Hospital Pharmacy
II. Online Pharmacy
III. Retail Pharmacy
5. Hepatitis C Major Treatments Market Share…………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Gilead, Company overview, Product & Services, Strategies & Financials
B. Pharco overview, Product & Services, Strategies & Financials
C. Pharmed, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………….
A. New Trends and Development of Hepatitis C Disease market
B. Future Opportunities
10. Conclusion

By Drug Type

On the basis of antiviral drug type, the market is segmented into entecavir, tenofovir, lamivudine, adefovir, telbivudine, and others

By Route of Administration

By route of administration, the treatment market has been segmented into oral and parenteral and others.

By End-User

By end-user, the treatment market is segmented into hospital and Clinics, Diagnostic Centres, and others.

Distribution Channel

On the basis of distribution channel, the global hepatic antiviral drugs market can be segmented into hospital pharmacy, online pharmacy, and retail pharmacy.

Major Players

Egypt’s Hepatitis C treatment market is fragmented into local and global companies including Hikma, Novartis, Roche, AstraZeneca, Sanofi, EIPICO, GSK, Pharco, Amoun Pharmaceutical Company, Eva Pharma, Pfizer, Magic Pharma, Pharmed, Hetero. These are expected to lead the market in the forecast period.

In 2015, the Egyptian government successfully negotiated with US-based Gilead Sciences’ in importing its Hepatitis C treatments of Sovaldi (sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) at heavily discounted prices.

Egypt, India, and Pakistan have secured very low prices for DAAs across regimens as they are scaling up public programs rapidly and moving towards HCV elimination.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements